Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension

NCT02238535 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

NETWORK

Sponsor class

Conditions

Residual Pulmonary Hypertension

Interventions

DRUG: Ventavis
DRUG: Warfarin

Sponsor

Meshalkin Research Institute of Pathology of Circulation